Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer.
about
Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trialPhase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.Docetaxel/trastuzumab combination therapy for the treatment of breast cancer.Docetaxel in the treatment of breast cancer: current experience and future prospects.Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer.Platinum-based compounds for the treatment of metastatic breast cancer.Raman microspectroscopy for probing the impact of a dietary antioxidant on human breast cancer cells.Results of two open-label, multicenter phase II studies of docetaxel, platinum salts, and trastuzumab in HER2-positive advanced breast cancer.In vitro and in vivo cytotoxic effect of AntiGan against tumor cells.Trastuzumab plus capecitabine vs. lapatinib plus capecitabine in patients with trastuzumab resistance and taxane-pretreated metastatic breast cancer.Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway.
P2860
Q24799659-7BE2F7C7-D58D-4956-9F91-F8B12D3B0266Q33391344-C0F002A9-C9D0-4280-A1A4-BE5004501053Q36222001-BCDB3E5E-0ABE-41D5-87AC-DC46E676CB90Q36235546-C1424E12-4B31-49EC-B9A1-1D34D54E2604Q36649028-B47FBE46-DF8B-4EF3-82F6-86B1241CE44DQ37976172-EC13C8C9-2A69-4819-8C78-B6DE606E7B97Q39734666-1905CE85-DE52-4E0E-984E-70AD6AD4F1A9Q42627458-C9498524-DF4A-4FA5-97A4-E8E355263010Q50287987-F5A59ABB-2DB6-4872-9C87-D570B57D25E7Q50943615-CF185278-CFA3-4452-B65F-7DD9F2E8637FQ52719999-4A60D3EC-9492-45FC-A6EB-6CA34BC0717D
P2860
Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Docetaxel-cisplatin combinatio ...... istant advanced breast cancer.
@ast
Docetaxel-cisplatin combinatio ...... istant advanced breast cancer.
@en
Docetaxel-cisplatin combination
@nl
type
label
Docetaxel-cisplatin combinatio ...... istant advanced breast cancer.
@ast
Docetaxel-cisplatin combinatio ...... istant advanced breast cancer.
@en
Docetaxel-cisplatin combination
@nl
prefLabel
Docetaxel-cisplatin combinatio ...... istant advanced breast cancer.
@ast
Docetaxel-cisplatin combinatio ...... istant advanced breast cancer.
@en
Docetaxel-cisplatin combination
@nl
P2093
P356
P1433
P1476
Docetaxel-cisplatin combinatio ...... istant advanced breast cancer.
@en
P2093
P304
P356
10.1023/A:1008318523058
P577
1999-12-01T00:00:00Z